Thoughts on the FDA Guidance to Assure Racial and Ethnic Diversity in Clinical Trials
Background On 13 April 2022 the Food and Drug Administration (FDA) issued a new draft guidance for ‘developing plans to enroll more...
Thoughts & Musings
Thoughts on the FDA Guidance to Assure Racial and Ethnic Diversity in Clinical Trials
Welcome to 2023
Long Haul COVID
Ethical Reflections on CRISPR Technology
Pandemic Persists Through Inequality
Welcome to 2022
Diversity in Clinical Trials
What Is Clinical Research?
Clinical Data Standards
The Culture Ignorance in America
Vulnerability and Autism
The Journey from Army to Science & Healthcare